, Tracking Stock Market Picks
Enter Symbol:

up 839.48 %

MEDIVATION INC (MDVN) rated Outperform by William Blair

Posted on: Friday,  Sep 16, 2011  1:25 PM ET by William Blair

William Blair rated Outperform MEDIVATION INC (NASDAQ: MDVN) on 09/16/2011, when the stock price was $9.80. Since
then, MEDIVATION INC has gained 839.49% as of 01/27/2016's recent price of $92.07.
If you would have followed this William Blair's recommendation on MDVN, you would have gained 839.48% of your investment in 1594 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/16/2011 1:25 PM Buy
as of 12/30/2011
1 Week up  1.02 %
1 Month up  0.34 %
3 Months up  171.55 %
1 YTD up  135.25 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy